Senti Biosciences earnings were -$52.8M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest SNTI earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$610.0k, down 97.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SNTI reported annual earnings of -$52.8M, with -25.7% growth.
What were Senti Biosciences's earnings last quarter?
Senti Biosciences (NASDAQ: SNTI) reported Q4 2024 earnings per share (EPS) of -$0.62, up 85.2% year over year. Total SNTI earnings for the quarter were -$610.00 thousand. In the same quarter last year, Senti Biosciences's earnings per share (EPS) was -$4.19.
As of the last Senti Biosciences earnings report, Senti Biosciences is currently losing money. Senti Biosciences's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$52.79 million, a 25.71% decrease year over year.
What was SNTI's earnings growth in the past year?
As of Senti Biosciences's earnings date in Q2 2025, Senti Biosciences's earnings has grown year over year. SNTI earnings in the past year totalled -$52.79 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.